Risk factor
Low price volatility
Profitability factor
Weak margins and returns
About
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, reasona
Target Price
The average target price of BAYRY is 15 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell